Publications, articles de presse, classements, awards et évènements à venir
Stay of proceedings in case of parallel proceedings before the UPC and the EPO: the Paris Central Division dismisses the request
In an order dated 8 January 2024, the Paris Central Division interpreted for the first time article 33 (10) of the Agreement concerning the stay of proceedings in the event of parallel proceedings likely to challenge the validity of the patent before the EPO.
Involvement of technical judges from the stage of the provisional measures
Procedural order, 25 January 2024 – Düsseldorf Local Division – UPC_CFI_452/2023
Pharma and Biotech Patent Litigation: Is the UPC changing litigation strategies?
The Pharma and Biotech Patent Litigation Europe summit which has taken place in Amsterdam was a good opportunity to get an overview from the EPO of the state of play.
Some criteria for choosing between unitary patent and national validations of the european patent
From 1 January 2023, the period for early uptake of the Unitary Patent begins and related official forms are available on the EPO website. The Unitary Patent system is expected to enter into force on 1 June 2023, when the Unified Patent Court (UPC) should also come into operation, heralding a new era for patent protection in Europe.
The start of the Sunrise Period postponed by two months
The Sunrise Period of the Unified Patent Jurisdiction was supposed to start on 1 January 2023, with a goal of the jurisdiction becoming operational on 1 April 2023. In a press release dated 5 December 2022, the Court states that this timetable is postponed by two months. The Sunrise Period will therefore start on 1 March 2023, with the aim of the Court coming into force on 1 June 2023.
Record Filings at the European Patent Office in 2021
Despite the pandemic filings of European patent applications increased again. 188 600 patent applications were received by European Patent Office (EPO) in 2021, which is an increase of 4.5% in comparison to the previous year.